Glaxo Group Limited 2010. N- inden- 2 -yl- isopropylsulfonamides as ampa receptor potentiators. WO2010057865A1. [Patent]. |
Abstract
A compound of formula (I) and salts thereof are provided: Wherein n and R 1 are defined in the specification. Pro¬ cesses for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment,are also disclosed.
Item Type: | Patent |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > R Medicine (General) |
Last Modified: | 25 Oct 2022 13:10 |
URI: | https://orca.cardiff.ac.uk/id/eprint/119061 |
Actions (repository staff only)
Edit Item |